Intravascular catheters impregnated with antimicrobial agents: A milestone in the prevention of bloodstream infections

Supportive Care in Cancer

Volumn 7, Issue 6, 1999, Pages 386-390

  Raad, Issam ^a   Hanna, Hend ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Antimicrobial impregnated catheters; Catheter related infections; Chlorhexidine silver sulfadiazine; Minocycline Rifampin

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE; MINOCYCLINE; RIFAMPICIN; SULFADIAZINE SILVER;

ANAPHYLAXIS; ANTIBIOTIC RESISTANCE; CANCER PATIENT; CANDIDA ALBICANS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; COST BENEFIT ANALYSIS; CRITICAL ILLNESS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS;

ANAPHYLAXIS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BACTEREMIA; BACTERIAL INFECTIONS; CATHETERS, INDWELLING; CHLORHEXIDINE; COATED MATERIALS, BIOCOMPATIBLE; ENZYME INHIBITORS; HUMANS; MINOCYCLINE; RIFAMPIN; RISK ASSESSMENT; RISK FACTORS; SILVER SULFADIAZINE;

EID: 0032859177     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050297     Document Type: Review

References (29)

1. Bach A, Bohrer H, Motsch J, Martin E. Geiss HK, Sonntag HG (1994) Prevention of bacterial colonization of intravenous catheters by antiseptic impregnation of polyurethane polymers. J Antimicrob Chemother 33:969-978
2. Centers for Devices and Radiological Health (1998) Potential hypersensitivity reactions to chlorhexidine-impregnated medical devices. Washington, DC, US Food and Drug Administration; FDA public health notice available at http:/www/fda. gov/cdrh/chlorhex.html
3. Ciresi D, Albrecht RM, Volkers PA, Scholten DJ (1996) Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am J Surg 62:641-646
4. Darouiche RO, Raad II, Bodey GP, Musher DM (1995) Antibiotic susceptibility of staphylococcal isolates from patients with vascular catheter-related bacteremia: potential role for the combination of minocycline and rifampin. Antimicrob Agents Chemother 6:31-36
5. Darouiche RO, Raad II, Heard SO. Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N. Hanna H, Hachem R, Harris RL. Mayhall G, for the Catheter Study Group. (1999) N Engl J Med 340:1-8
6. Greenfield JI, Sampath L, Popiskis SJ, Brunnert SR, Stylianos S, Modak S (1995) Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine. Crit Care Med 23:894-900
7. Harvey A, Alcid DV, Greco RS (1982) Antibiotic bonding to polytetrafluoroethylene with tridodecylmethylammonium chloride. Surgery 92:504-512
8. Heard SO, Wagle M, Vijayakumar E, Doern G (1997) The Influence of central venous catheters coated with chlorhexidine/silver sulfadiazine on catheter-related infections (abstract). Crit Care Med 25 [Suppl]:A1 17
9. Heiselman D (1994) Nosocomial bloodstream infection in the critically ill (letter). JAMA 272:1819-1820
10. Kamal GD, Pfaller MA, Rempe LE, Jebson FJR (1991) Reduced intravascular catheter infection by antibiotic bonding: a prospective, randomized, controlled trial. JAMA 265:2364-2368
11. Maki DC, Garman JK, Shapiro JM, Ringer M, Helgerson RB (1988) An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med 85:307-314
12. Maki DG, Stolz SM. Wheeler S, Mermel LA (1997) Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 127:257-266
13. Mermel LA, Stolz SM, Maki DG (1993) Surface antimicrobial activity of heparin bonded and antiseptic impregnated vascular catheters. J Infect Dis 167:920-924
14. Oda T, Junichiro H, Naomi K. Mikami K (1997) Anaphylactic shock induced by an antiseptic-coated central venous catheter. Anesthesiology 87:1242-1244
15. Pemberton LB, Ross V, Cuddy P, Kremer H, FesslerT, McGurk E. (1996) No difference in catheter sepsis between standard and antiseptic central venous catheters. A prospective randomized trial. Arch Surg 131:986-989
16. Pittet D, Tarara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality (editorial). JAMA 271:1598-1601
17. Raad I (1997) Vascular catheters impregnated with antimicrobial agents: present knowledge and future direction. Infect Control Hosp Epidemiol 18:227-229
18. Raad I, Safar H (1997) Long-term central venous catheters. Infectious complications and cost. In: Seifert H, Jansen B, Farr BM (eds) Catheter-related infections. Dekker, New York Basel Hong Kong, pp 307-324
19. Raad I, Costerton W, Sabbarwal U, Sacilowski M, Anaissie E, Bodey GP (1993) Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168:400-407
20. Raad I, Darouiche R, Hachem R, Sacilowski M, Bodey GP (1995) Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 39:2397-2400
21. Raad I, Darouiche R, Hachem R, Mansour M, Bodey GP (1996) The broad spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 173:418-424
22. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burket, Ericsson C, and the Texas Medical Center Catheter Study Group (1997) Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med 127:267-274
23. Raad I, Darouiche RO, Hachem R, Abi-Said D, Safar H, Darnule T, Mansouri M. Morck D (1998) Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit Care Med 26:219-224
24. Sherertz RJ, Carruth A, Hampton AA, Byron MP, Solomon DD (1993) Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis 167:98-106
25. Sherertz RJ, Forman DM. Solomon DD (1989) Efficacy of dicloxacillincoated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice. Antimicrob Agents Chemother 33:1174-1178
26. Trooskin SZ, Donetz AP, Harvey RA, Greco RS (1985) Prevention of catheter sepsis by antibiotic bonding. Surgery 97:547-551
27. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD (1999) Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection. A meta-analysis. JAMA 281:261-267
28. Wenzel RP, Edmond MB (1999) The evolving technology of venous access. N Engl J Med 340:48-50
29. World Health Organization (1997) Central venous catheters (Arrowguard) recalled: anaphylactic shock (alert 62). World Health Organization. Geneva